Business Description
Organon & Co
NAICS : 325412
SIC : 2834
ISIN : US68622V1061
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | -0.01 | |||||
Debt-to-Equity | -125.14 | |||||
Debt-to-EBITDA | 6.1 | |||||
Interest Coverage | 2.52 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.28 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.8 | |||||
3-Year EBITDA Growth Rate | -21.2 | |||||
3-Year EPS without NRI Growth Rate | -23.5 | |||||
3-Year FCF Growth Rate | -35 | |||||
Future 3-5Y Total Revenue Growth Rate | 3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.19 | |||||
9-Day RSI | 47.77 | |||||
14-Day RSI | 49.77 | |||||
6-1 Month Momentum % | 8.38 | |||||
12-1 Month Momentum % | -19.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 169.05 | |||||
Days Sales Outstanding | 93.06 | |||||
Days Payable | 163.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.1 | |||||
Dividend Payout Ratio | 0.18 | |||||
Forward Dividend Yield % | 6.15 | |||||
5-Year Yield-on-Cost % | 3.1 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 10.37 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.84 | |||||
Operating Margin % | 21.19 | |||||
Net Margin % | 16.33 | |||||
FCF Margin % | 8.58 | |||||
ROE % | Neg. Equity | |||||
ROA % | 9.17 | |||||
ROIC % | 24.87 | |||||
ROC (Joel Greenblatt) % | 57.26 | |||||
ROCE % | 13.92 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 4.46 | |||||
PE Ratio without NRI | 5.55 | |||||
PS Ratio | 0.73 | |||||
Price-to-Free-Cash-Flow | 8.49 | |||||
Price-to-Operating-Cash-Flow | 5.72 | |||||
EV-to-EBIT | 10.54 | |||||
EV-to-EBITDA | 8.81 | |||||
EV-to-Revenue | 2.02 | |||||
EV-to-FCF | 23.46 | |||||
Earnings Yield (Greenblatt) % | 9.49 | |||||
FCF Yield % | 11.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Organon & Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5,809.345 | ||
EPS (TTM) (€) | 3.69 | ||
Beta | 0 | ||
Volatility % | 53.87 | ||
14-Day RSI | 49.77 | ||
14-Day ATR (€) | 0.283418 | ||
20-Day SMA (€) | 16.72575 | ||
12-1 Month Momentum % | -19.97 | ||
52-Week Range (€) | 10.15 - 21.56 | ||
Shares Outstanding (Mil) | 255.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Organon & Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Organon & Co Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Organon & Co Frequently Asked Questions
What is Organon & Co(XTER:7XP)'s stock price today?
When is next earnings date of Organon & Co(XTER:7XP)?
Does Organon & Co(XTER:7XP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |